Angiogenesis in B-Cell Chronic Lymphocytic Leukemia: Methods of Study, Clinical Significance and Prognostic Implications

References

• Folkmann J. Angigenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Gasparini G, Harris A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. Journal of clinical Oncology 1995; 13: 765–782
   PubMed Web of Science ®Google Scholar
• Esch F., Baird A., Ling N., Ueno N., Hill F., Deneroy L. Primary structure of bovine fibroblastic growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acid FGF. Proceedings of the National Academy of Sciences of America 1985; 82: 6507–6511
   PubMed Web of Science ®Google Scholar
• Nakamura T., Nawa K., Ichiara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochemical and Biophysical Research Communications 1984; 122: 1450–1459
   PubMed Web of Science ®Google Scholar
• Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., Ria R., Albini A., Bussolino F., Dammacco F. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood, 93: 3064–3073
   PubMed Web of Science ®Google Scholar
• Perez-Atayde A. R., Sallan S. E., Tedrow U., Connors E. A., Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. American Journal of Pathology 1997; 150: 815–821
   PubMed Web of Science ®Google Scholar
• Shami P. J., Hussong J. W., Rodgers G. M. Evidence of increased angiogenesis in the bone marrow with acute non-lymphocytic leucemia. Blood 1998; 92: 1998, 2105, Suppl. 1
   Web of Science ®Google Scholar
• Hussong J. W., Rodgers G. M., Shami P. Evidence of increased angiogenesis in patients with acute myeloid leukaemia. Blood 2000; 95: 309–313
   PubMed Web of Science ®Google Scholar
• Aguayo A., O'Brien S., Keating M., Manshouri T., Gidel C., Barlogie B., Beran M., Koller C., Kantarajian H., Albitar M. Clinical relevance of vascular endothelial growth factor levels in B-cell chronic lymphocytic leukaemia. Blood 2000; 96: 768–770
   PubMed Web of Science ®Google Scholar
• Kini A. R., Kay N. E., Peterson L. C. Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414–1418
   PubMed Web of Science ®Google Scholar
• Aguayo A., Kantarajian H., Manshouri T., Gidel C., Estey E., Thomas D., Koller C., Estov Z., O'Brien S., Keating M., Freireich E., Albitar M. Angiogenesis in acute and chronic leukaemia and myelodysplastic syndromes. Blood 2000; 96: 2240–2245
   PubMed Web of Science ®Google Scholar
• Chen H., Treeweeke A. T., West D. C., Till K. J., Cawley J. C., Zuzel M., Toh C. H. In vitro and in vivo production of vascular endothelial growth factor chronic lymphocytic leukaemia cells. Blood 2000; 96: 3181–3187
   PubMed Web of Science ®Google Scholar
• Molica S., Vitelli G., Levato D., Gandolfo G. M., Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. British Journal of Haematoogy 1999; 107: 605–610
   PubMed Web of Science ®Google Scholar
• Mangi M. H., Newland A. C. Angiogenesis and angiogenetic mediators in haematological maligniances. British Journal of Haematoogy 2000; 111: 43–51
   PubMed Web of Science ®Google Scholar
• Vcan de Rijin M., Rouse R. V. CD34 a Review. Applied Immunohistochemistry 1994; 2: 71–80
   Google Scholar
• Menzel T., Rahaman Z., Calleja P., White K., Wilson E. L., Wieder R., Gabrilove J. Elevated intracellular levels of basic fibroblastic growth factor correlate with stage of chronic lymphocytic leukaemia and is associated with resistance to fludarabine. Blood 1996; 87: 1056–1063
   PubMed Web of Science ®Google Scholar
• Konig A., Menzel T., Linsen S., Wrazel L., Rosen A., Al Katib A., Raveche E.J.L. Basic fibroblastic growth factor (b-FGF) upregulates the expression of bcl-2 in B-cell chronic lymphocytic leukaemia cell lines resulting in delaying apoptosis. Leukemia 1997; 11: 258–265
   PubMed Web of Science ®Google Scholar
• Baban D. F., Murray J. A., Earl H. M., Kerr D. J., Seymour L. W. Quantitative analysis of vascular endothelial growth expression in chronic lymphocytic leukaemia. Internal Journal Of Oncology 1996; 8: 29–34
   PubMed Web of Science ®Google Scholar
• Foss H. D., Araujo I., Demel G., Klotzbach H., Hummel M., Stein H. Expression of vascular endothelial growth factor in lymphomas and Castelman's disease. Journal of Pethology 1997; 183: 44–50
   PubMed Web of Science ®Google Scholar
• Molica S., Santoro R., Digiesi G., Dattili A., Levato Muleo D. Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukaemia. Haematlogica 2000; 85: 1106–1108
   PubMed Web of Science ®Google Scholar
• Salven P., Teerenhovi L, Joensuu H. A high pre-treatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90: 3167–3172
   PubMed Web of Science ®Google Scholar
• Salven P., Teerenhovi L, Joensuu H. A high pre-treatment serum basic fibroblastic growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma. Blod 1999; 94: 3334–3339
   PubMed Web of Science ®Google Scholar
• Salven P., Orpana A., Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of thr angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin's lymphoma: a single-institutions study o0f 200 patients. Blood 2000; 94: 3334–3339
   Google Scholar
• Molica S., Vitelli G., Levato D., Ricciotti A., Gandolfo G. M. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor as predictor disease-progression in early B-cell chronic lymphocytic leukaemia. Blood 2000; 96: 369a, Suppl. 1
   PubMed Web of Science ®Google Scholar